Skip to main content

Earnings Power Value

Updated Jun 24, 2026 at 2:35pm

Research Draft High 1,270 words

Earnings Power Value (EPV) is a valuation method that estimates what a company is worth based only on its current, sustainable earnings — assuming zero future growth. Popularized by Columbia Business School professor Bruce Greenwald in Value Investing: From Graham to Buffett and Beyond (2001), it deliberately strips out the most speculative input in valuation (the growth forecast) and asks a narrower, more defensible question: if this business simply maintains its current normalized earning power forever, what is that worth? Its core tension is exactly this trade-off — by refusing to forecast growth, EPV gains discipline and falsifiability, but it systematically undervalues genuinely growing franchises and must be paired with judgment about whether "no growth" is conservative or naive.

How it's calculated / formed

The headline formula is simple; the work is in the numerator.

EPV (enterprise) = Adjusted (normalized, distributable) earnings ÷ Cost of capital (WACC)

The earnings figure is normalized maintainable earnings, built roughly as follows (Greenwald's sequence, as summarized by StableBread, Wall Street Prep, and Finbox):

1. Normalize the operating margin. Average EBIT margin over a full business cycle — typically 5+ years (some practitioners use 3–7) — to smooth cyclical peaks and troughs, then apply it to current "sustainable" revenue to get normalized EBIT. The goal is mid-cycle earning power, not a single good or bad year. 2. Strip one-time items — restructuring charges, litigation, asset-sale gains — that don't recur. 3. Tax-effect to NOPAT: Normalized EBIT × (1 − normalized effective tax rate). 4. Adjust for the depreciation/maintenance-capex gap. Greenwald separates maintenance capex (spending needed to keep current capacity intact) from growth capex (which is excluded entirely under the no-growth premise). Reported depreciation rarely equals true maintenance capex, so an adjustment — sometimes expressed as adding back a fraction of excess depreciation on an after-tax basis — converts accounting earnings toward distributable cash earnings. 5. Divide by WACC to capitalize this perpetuity (a zero-growth perpetuity is simply earnings ÷ discount rate). 6. Bridge to equity: subtract net debt (and other non-operating claims), add cash and the value of non-operating assets, to move from enterprise EPV to equity value per share.

A note on the denominator: capitalizing a no-growth stream by WACC is internally consistent only because there is no reinvestment-for-growth being valued. Some practitioners instead use a personal required rate of return rather than a textbook WACC.

How it's used in practice

EPV's most powerful use is comparative, not as a single point estimate. Greenwald embeds it in a three-layer framework:

  • Asset Reproduction Value (ARV) — what it would cost a competitor to rebuild the company's asset base from scratch.
  • Earnings Power Value (EPV) — value of current earnings, no growth.
  • Franchise / growth value — anything above the first two.

The diagnostic spread is EPV vs. ARV:

  • EPV ≈ ARV → a competitive, no-moat business; earnings just cover the cost of the assets, as economic theory predicts for a market with free entry.
  • EPV > ARV → the gap is franchise value — evidence of a durable competitive advantage (brand, network, switching costs, scale economics) letting the firm earn returns above its cost of capital. Greenwald insists this gap is only credible if you can name the barrier to entry causing it.
  • EPV < ARV → a red flag: management is destroying value, earnings are below what the assets should produce, and the assets may be worth more redeployed or liquidated.

Analysts also use EPV as a conservative floor or sanity check against a DCF: if a DCF only "works" because it bakes in years of high growth, comparing it to EPV exposes how much of the price is paying for a growth story versus what exists today. The margin of safety is then the gap between EPV-derived value and market price.

Adoption, debate & evidence

EPV is well known within the value-investing community but is a niche, practitioner technique rather than a mainstream sell-side standard — DCF and relative multiples dominate institutional practice. It is taught in Greenwald's value-investing program and widely covered by value-focused educators (GuruFocus, Old School Value, Wall Street Prep, Finbox), which is itself a signal that its credibility rests largely on logical/pedagogical appeal and the reputation of value investing, not on a body of peer-reviewed return studies.

Important honesty point: there is little rigorous academic evidence isolating "EPV-based selection" as a return-generating strategy. Its intellectual backing comes from broader, well-documented value-investing research (e.g., the value premium of Fama–French, and the long track record of Graham-style approaches), not from studies testing EPV per se. Claims that "EPV beats the market" should be treated as unproven — the method is best defended as a disciplined valuation lens, not a backtested edge.

The genuine debates: (1) maintenance capex is not disclosed and must be estimated, making the most important adjustment partly subjective; (2) the "normalize then assume forever" premise can badly misprice both decliners (assumes stability that won't hold) and compounders (assigns zero value to durable growth); (3) WACC choice swings the answer materially, just as in DCF.

Strengths & limitations

Strengths. Forecast-light and therefore harder to fudge than DCF; well suited to mature, stable, cyclical-but-mean-reverting businesses (industrials, consumer staples, utilities) where current earnings genuinely approximate maintainable earnings. The EPV-vs-ARV comparison is a rare valuation tool that directly tests for the existence of a moat rather than assuming one.

Limitations. It assigns no value to growth, so it will look hopelessly low on a true compounder and is the wrong primary tool for high-growth or early-stage names. It is only as good as the normalization — garbage margins, mis-estimated maintenance capex, or a distorted cycle window produce confident-looking but wrong numbers. It assumes the current business configuration is sustainable indefinitely, which fails for firms in secular decline or rapid technological change.

The #1 misuse: treating EPV's no-growth output as a prediction rather than a baseline. A low EPV doesn't mean "buy because it's cheap on no growth"; it may mean the no-growth assumption is wrong (the business is shrinking). EPV tells you what you're getting for free if you pay EPV — it does not tell you the growth assumption is safe.

Sources

Flagged dispute: No peer-reviewed evidence isolates EPV as a return-generating strategy; its credibility derives from value-investing logic and the value premium literature generally, not from EPV-specific backtests. Maintenance-capex normalization is acknowledged across sources as the method's most subjective, outcome-determining step.